21.35 USD
▲-0.60+11.49%
盘后 19.15 0.00%
2026-08-03
市值
$1.27B
市盈率
—
EPS
-2.11
股息率
—
52 周区间
6.67 – 28.00
成交量
1.69M
Beta
—
目标价
48.50
52W 低 6.6752W 高 28.00
价格走势
公司简介
Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. It develops JADE101, a monoclonal antibody to block the A PRoliferation Inducing Ligand protein, which is in phase 1 clinical trial. The company also develops JADE201 and JADE-003, which are in preclinical development stage. Jade Biosciences, Inc. has a collaboration agreement with Paragon Therapeutics, Inc. Jade Biosciences, Inc. is based in Waltham, Massachusetts.